Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons

Original Article

C.F. Kelley, M. Acevedo-Quiñones, A.L. Agwu, A. Avihingsanon, P. Benson, J. Blumenthal, C. Brinson, C. Brites, P. Cahn, V.D. Cantos, J. Clark, M. Clement, C. Creticos, G. Crofoot, R.S. Diaz, S. Doblecki-Lewis, J.A. Gallardo-Cartagena, A. Gaur, B. Grinsztejn, S. Hassler, J.C. Hinojosa, T. Hodge, R. Kaplan, M. Lacerda, A. LaMarca, M.H. Losso, J.V. Madruga, K.H. Mayer, A. Mills, K. Mounzer, N. Ndlovu, R.M. Novak, A.P. Rios, N. Phanuphak, M. Ramgopal, P.J. Ruane, J. Sánchez, B. Santos, P. Schine, T. Schreibman, L.Y. Spencer, O.T.V. Gerwen, R. Vasconcelos, J.G. Vasquez, Z. Zwane, S. Cox, C. Deaton, R. Ebrahimi, P. Wong, R. Singh, L.B. Brown, C.C. Carter, M. Das, J.M. Baeten, and O. Ogbuagu

N Engl J Med 2025;392:1261-1276

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Course opens: 
04/02/2025
Course expires: 
04/03/2027

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Please sign in or create an account to take the course.